| DLC1 promotes mechanotransductive feedback for YAP via RhoGAP-mediated focal adhesion turnover. | DLC1 promotes mechanotransductive feedback for YAP via RhoGAP-mediated focal adhesion turnover.
Hooglugt A, van der Stoel MM, Shapeti A, Neep BF, de Haan A, van Oosterwyck H, Boon RA, Huveneers S., Free PMC Article | 05/10/2024 |
| Aberrant DNA Methylation Patterns of Deleted in Liver Cancer 1 Isoforms in Hepatocellular Carcinoma. | Aberrant DNA Methylation Patterns of Deleted in Liver Cancer 1 Isoforms in Hepatocellular Carcinoma.
Pan J, Li D, Fan X, Cheng J, Jin S, Chen P, Lin H, Li Y. | 03/20/2023 |
| NBR2/miR-561-5p/DLC1 axis inhibited the development of multiple myeloma by activating the AMPK/mTOR pathway to repress glycolysis. | NBR2/miR-561-5p/DLC1 axis inhibited the development of multiple myeloma by activating the AMPK/mTOR pathway to repress glycolysis.
Wang CS, Zhang XB, Zhu XT, Chen RS. | 10/22/2022 |
| Frequent Downregulation and Promoter Hypermethylation of DLC1: Relationship with Clinical Outcome in Gallbladder Cancer. | Frequent Downregulation and Promoter Hypermethylation of DLC1: Relationship with Clinical Outcome in Gallbladder Cancer.
Singh D, Bharti A, Biswas D, Tewari M, Kar AG, Ansari MA, Singh S, Narayan G. | 06/18/2022 |
| MiR-200a-3p promotes gastric cancer progression by targeting DLC-1. | MiR-200a-3p promotes gastric cancer progression by targeting DLC-1.
Li Z, Wang Y, Liu S, Li W, Wang Z, Jia Z, Zhu Z, Bao Y. | 03/26/2022 |
| The tumor suppressor activity of DLC1 requires the interaction of its START domain with Phosphatidylserine, PLCD1, and Caveolin-1. | The tumor suppressor activity of DLC1 requires the interaction of its START domain with Phosphatidylserine, PLCD1, and Caveolin-1.
Sanchez-Solana B, Wang D, Qian X, Velayoudame P, Simanshu DK, Acharya JK, Lowy DR., Free PMC Article | 02/26/2022 |
| Association of deleted in liver cancer-1 gene polymorphism with increased risk of chronicity of disease among Malaysian patients with hepatitis B infection. | Association of deleted in liver cancer-1 gene polymorphism with increased risk of chronicity of disease among Malaysian patients with hepatitis B infection.
Riazalhosseini B, Mohamed R, Devi Apalasamy Y, Mohamed Z. | 01/29/2022 |
| DLC1 inhibits lung adenocarcinoma cell proliferation, migration and invasion via regulating MAPK signaling pathway. | DLC1 inhibits lung adenocarcinoma cell proliferation, migration and invasion via regulating MAPK signaling pathway.
Niu N, Ma X, Liu H, Zhao J, Lu C, Yang F, Qi W. | 01/22/2022 |
| CircZKSCAN1 Suppresses Hepatocellular Carcinoma Tumorigenesis by Regulating miR-873-5p/Downregulation of Deleted in Liver Cancer 1. | CircZKSCAN1 Suppresses Hepatocellular Carcinoma Tumorigenesis by Regulating miR-873-5p/Downregulation of Deleted in Liver Cancer 1.
Li J, Bao S, Wang L, Wang R. | 12/11/2021 |
| MIR-301b-3p Promotes Lung Adenocarcinoma Cell Proliferation, Migration and Invasion by Targeting DLC1. | MIR-301b-3p Promotes Lung Adenocarcinoma Cell Proliferation, Migration and Invasion by Targeting DLC1.
Liu H, Ma X, Niu N, Zhao J, Lu C, Yang F, Qi W., Free PMC Article | 11/13/2021 |
| DLC1 is a direct target of activated YAP/TAZ that drives collective migration and sprouting angiogenesis. | DLC1 is a direct target of activated YAP/TAZ that drives collective migration and sprouting angiogenesis.
van der Stoel M, Schimmel L, Nawaz K, van Stalborch AM, de Haan A, Klaus-Bergmann A, Valent ET, Koenis DS, van Nieuw Amerongen GP, de Vries CJ, de Waard V, Gloerich M, van Buul JD, Huveneers S. | 08/7/2021 |
| Tumor suppressor gene DLC1: Its modifications, interactive molecules, and potential prospects for clinical cancer application. | Tumor suppressor gene DLC1: Its modifications, interactive molecules, and potential prospects for clinical cancer application.
Ren G, Li G. | 07/31/2021 |
| Screening for the Biomarkers Associated with Myocardial Infarction by Bioinformatics Analysis. | Screening for the Biomarkers Associated with Myocardial Infarction by Bioinformatics Analysis.
Zhang G, Li J, Sun H, Yang G. | 07/31/2021 |
| Circular RNA circDLC1 inhibits MMP1-mediated liver cancer progression via interaction with HuR. | Circular RNA circDLC1 inhibits MMP1-mediated liver cancer progression via interaction with HuR.
Liu H, Lan T, Li H, Xu L, Chen X, Liao H, Chen X, Du J, Cai Y, Wang J, Li X, Huang J, Yuan K, Zeng Y., Free PMC Article | 07/24/2021 |
| TMEM106C contributes to the malignant characteristics and poor prognosis of hepatocellular carcinoma. | TMEM106C contributes to the malignant characteristics and poor prognosis of hepatocellular carcinoma.
Duan J, Qian Y, Fu X, Chen M, Liu K, Liu H, Yang J, Liu C, Chang Y., Free PMC Article | 07/24/2021 |
| MicroRNA-141-3p promoted the progression of nasopharyngeal carcinoma through targeting DLC1. | MicroRNA-141-3p promoted the progression of nasopharyngeal carcinoma through targeting DLC1.
Mu JW, Zhou XY, Wang QJ, Han LH, Jiao JB. | 07/3/2021 |
| Oncogenic Role of miR-200c-3p in High-Grade Serous Ovarian Cancer Progression via Targeting the 3'-Untranslated Region of DLC1. | Oncogenic Role of miR-200c-3p in High-Grade Serous Ovarian Cancer Progression via Targeting the 3'-Untranslated Region of DLC1.
Ankasha SJ, Shafiee MN, Abdul Wahab N, Raja Ali RA, Mokhtar NM., Free PMC Article | 07/3/2021 |
| Curcumin inhibits the growth of triple-negative breast cancer cells by silencing EZH2 and restoring DLC1 expression. | Curcumin inhibits the growth of triple-negative breast cancer cells by silencing EZH2 and restoring DLC1 expression.
Zhou X, Jiao D, Dou M, Zhang W, Lv L, Chen J, Li L, Wang L, Han X., Free PMC Article | 05/15/2021 |
| Identifying Cancer-Relevant Mutations in the DLC START Domain Using Evolutionary and Structure-Function Analyses. | Identifying Cancer-Relevant Mutations in the DLC START Domain Using Evolutionary and Structure-Function Analyses.
Holub AS, Bouley RA, Petreaca RC, Husbands AY., Free PMC Article | 03/20/2021 |
| A tumor suppressor DLC1: The functions and signal pathways. | A tumor suppressor DLC1: The functions and signal pathways.
Zhang Y, Li G. | 03/13/2021 |
| circRNA-associated ceRNA network construction reveals the circRNAs involved in the progression and prognosis of breast cancer. | circRNA-associated ceRNA network construction reveals the circRNAs involved in the progression and prognosis of breast cancer.
Ma X, Liu C, Gao C, Li J, Zhuang J, Liu L, Li H, Wang X, Zhang X, Dong S, Zhou C, Sun C. | 02/6/2021 |
| Cancer-Associated Point Mutations in the DLC1 Tumor Suppressor and Other Rho-GAPs Occur Frequently and Are Associated with Decreased Function. | Cancer-Associated Point Mutations in the DLC1 Tumor Suppressor and Other Rho-GAPs Occur Frequently and Are Associated with Decreased Function.
Wang D, Qian X, Sanchez-Solana B, Tripathi BK, Durkin ME, Lowy DR., Free PMC Article | 01/16/2021 |
| Nuclear DLC1 exerts oncogenic function through association with FOXK1 for cooperative activation of MMP9 expression in melanoma. | Nuclear DLC1 exerts oncogenic function through association with FOXK1 for cooperative activation of MMP9 expression in melanoma.
Yang X, Hu F, Liu JA, Yu S, Cheung MPL, Liu X, Ng IO, Guan XY, Wong KKW, Sharma R, Lung HL, Jiao Y, Lee LTO, Cheung M., Free PMC Article | 11/28/2020 |
| Inhibition of miR-141 and miR-200a Increase DLC-1 and ZEB2 Expression, Enhance Migration and Invasion in Metastatic Serous Ovarian Cancer. | Inhibition of miR-141 and miR-200a Increase DLC-1 and ZEB2 Expression, Enhance Migration and Invasion in Metastatic Serous Ovarian Cancer.
Wahab NA, Othman Z, Nasri NWM, Mokhtar MH, Ibrahim SF, Hamid AA, Raja Ali RA, Mokhtar NM., Free PMC Article | 09/26/2020 |
| DLC1 SAM domain-binding peptides inhibit cancer cell growth and migration by inactivating RhoA. | DLC1 SAM domain-binding peptides inhibit cancer cell growth and migration by inactivating RhoA.
Joshi R, Qin L, Cao X, Zhong S, Voss C, Min W, Li SSC., Free PMC Article | 09/19/2020 |